Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was troubled last month when Food and Drug Administration called for the sale stop of its leukemia drug in the U.S.Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock in last trading day opened at $6.57, traded the day range of $6.45-$6.98, and closed at $6.82. The stock showed a positive performance of 4.12% in previous trading session.
Pfizer Inc. (NYSE:PFE) stock got “Outperform” rating at Cowen and Company. The analyst at Cowen and Company has lowered the price target from $37.00 to $34.00 onIn last trading activity, Pfizer Inc. (NYSE:PFE) traded 6.48 Billion shares and the average volume of the stock was recorded as 24.58million shares. The 52 week range of the stock is $24.63 – $32.50. The stock was dropped -0.2.0% by closing at $30.63.
Galena Biopharma Inc (NASDAQ:GALE) announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, presented a corporate update at the Oppenheimer 24th Annual Healthcare Conference Shares of Galena Biopharma Inc (NASDAQ:GALE) closed at $4.29 during last trading session. Galena Biopharma Inc (NASDAQ:GALE) stock on December 31, 2013, recorded a rise of 2.90 % and was in a range of $ 4.80 – $5.30 before closing at $4.96. Company’s 52-week low price is $1.55 and 52 week high price is $5.30.
Merck & Co., Inc. (NYSE:MRK) is currently down from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NYSE Decliners Watch. Merck & Co., Inc. (NYSE:MRK) shares rose 0.22% in last trading session and was closed at $50.05, while trading in range of $ 49.53 – $50.08. Its return on equity ratio is recorded as 12.20% and its return on assets is 5.80%.